Prescription drug · ANDA
Zanaflex (Tizanidine hydrochloride) NDC 73352-090
Tizanidine hydrochloride 8 mg/1 · Capsule · Oral · Trifluent Pharma, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73352-090-60 | 7335200906073352009060 | 60 CAPSULE in 1 BOTTLE (73352-090-60)Marketed from Sep 16, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Zanaflex
- Generic name (nonproprietary)
- tizanidine hydrochloride
- Active ingredients
- Tizanidine hydrochloride — 8 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Trifluent Pharma, LLCNDC labeler code 73352
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213798
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha2-Agonists (Mechanism)
- Identifiers
- Product ID 73352-090_4007fbf6-8eb7-85e9-e063-6394a90a4013SPL ID 4007fbf6-8eb7-85e9-e063-6394a90a4013SPL set ID 9833a1b8-f530-4a06-bc77-7d11b6e94c65RxCUI 2723708, 2723710UNII B53E3NMY5CUPC 0373352090600
- Pharmacologic class
- Central alpha-2 Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473352009060followed by a unit qualifier and the quantityPackage 73352-0090-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Tizanidine hydrochloride is indicated for the treatment of spasticity in adults. Tizanidine hydrochloride is a central alpha-2-adrenergic agonist indicated for the treatment of spasticity. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 73352-090
- What is NDC 73352-090?
- 73352-090 is the product NDC for Zanaflex (tizanidine hydrochloride), Tizanidine hydrochloride 8 mg/1 capsule, listed with the FDA by Trifluent Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Zanaflex (Tizanidine hydrochloride).
- What is the active ingredient?
- Tizanidine hydrochloride.
- Who is the labeler?
- Trifluent Pharma, LLC, NDC labeler code 73352. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Zanaflex?
- 8 other product NDCs are listed under this name. See all Zanaflex NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Zanaflex products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Zanaflextizanidine hydrochloride | Tizanidine hydrochloride 4 mg/1 | TabletOral | Covis Pharma US, Inc | 70515-594 | 70515-0594-15 |
| Zanaflextizanidine hydrochloride | Tizanidine hydrochloride 2 mg/1 | CapsuleOral | Covis Pharma US, Inc | 70515-602 | 70515-0602-15 |
| Zanaflextizanidine hydrochloride | Tizanidine hydrochloride 4 mg/1 | CapsuleOral | Covis Pharma US, Inc | 70515-604 | 70515-0604-15 |
| Zanaflextizanidine hydrochloride | Tizanidine hydrochloride 6 mg/1 | CapsuleOral | Covis Pharma US, Inc | 70515-606 | 70515-0606-15 |
| Zanaflextizanidine hydrochloride | Tizanidine hydrochloride 2 mg/1 | CapsuleOral | Legacy Pharma USA, Inc. | 83107-001 | 83107-0001-15 |
| Zanaflextizanidine hydrochloride | Tizanidine hydrochloride 4 mg/1 | CapsuleOral | Legacy Pharma USA, Inc. | 83107-002 | 83107-0002-15 |
| Zanaflextizanidine hydrochloride | Tizanidine hydrochloride 6 mg/1 | CapsuleOral | Legacy Pharma USA, Inc. | 83107-003 | 83107-0003-15 |
| Zanaflextizanidine hydrochloride | Tizanidine hydrochloride 4 mg/1 | TabletOral | Legacy Pharma USA, Inc. | 83107-004 | 83107-0004-15 |
Other NDCs under ANDA 213798
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tizanidine | Tizanidine hydrochloride 6 mg/1 | CapsuleOral | Direct_Rx | 72189-678 |
| tizanidine hydrochloride | Tizanidine hydrochloride 4 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-8776 |
| tizanidine hydrochloride | Tizanidine hydrochloride 4 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-2559 |
| tizanidine hydrochloride | Tizanidine hydrochloride 6 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-2872 |
| tizanidine hydrochloride | Tizanidine hydrochloride 6 mg/1 | CapsuleOral | PD-Rx Pharmaceuticals, Inc. | 72789-505 |
| tizanidine hydrochloride | Tizanidine hydrochloride 2 mg/1 | CapsuleOral | PD-Rx Pharmaceuticals, Inc. | 72789-506 |
| tizanidine hydrochloride | Tizanidine hydrochloride 4 mg/1 | CapsuleOral | PD-Rx Pharmaceuticals, Inc. | 72789-507 |
| tizanidine hydrochloride | Tizanidine hydrochloride 2 mg/1 | CapsuleOral | Advagen Pharma Limited | 72888-001 |
| tizanidine hydrochloride | Tizanidine hydrochloride 4 mg/1 | CapsuleOral | Advagen Pharma Limited | 72888-002 |
| tizanidine hydrochloride | Tizanidine hydrochloride 6 mg/1 | CapsuleOral | Advagen Pharma Limited | 72888-003 |
| tizanidine hydrochloride | Tizanidine hydrochloride 8 mg/1 | CapsuleOral | Advagen Pharma Limited | 72888-161 |
| Tizanidine Hydrochloride | Tizanidine hydrochloride 8 mg/1 | CapsuleOral | Trifluent Pharma, LLC | 73352-089 |
| tizanidine hydrochloride | Tizanidine hydrochloride 4 mg/1 | CapsuleOral | Advanced Rx of Tennessee, LLC | 80425-0474 |